MacroGenics to Participate in Two Upcoming Investor Conferences
Nov 01, 2016 21:00 pm UTC| Business
Rockville, MD, Nov. 01, 2016 -- -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the...
FibroGen to Report Third Quarter 2016 Financial Results on November 8, 2016
Nov 01, 2016 21:00 pm UTC| Business
SAN FRANCISCO, Nov. 01, 2016 -- FibroGen, Inc. (NASDAQ:FGEN), a research-based biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics to treat serious unmet medical...
National Research Corporation Announces Third Quarter 2016 Results
Nov 01, 2016 21:00 pm UTC| Business
LINCOLN, Neb., Nov. 01, 2016 -- National Research Corporation (NASDAQ:NRCIA) (NASDAQ:NRCIB) today announced results for the third quarter of 2016. Net New Sales $5.2 millionTotal Contract Value $115.2 millionRevenue up...
Paragon Offshore To Announce Third Quarter 2016 Results
Nov 01, 2016 20:51 pm UTC| Business
HOUSTON, Nov. 01, 2016 -- Paragon Offshore plc (“Paragon”) (OTC:PGNPQ) announced today that it plans to report financial results for the third quarter 2016 on Tuesday, November 8, 2016, after the close of trading on the...
Great Elm Capital Group Announces Restart of its Rights Offering
Nov 01, 2016 20:45 pm UTC| Business
BOSTON, Nov. 01, 2016 -- Great Elm Capital Group, Inc. (NASDAQ:GEC) announced today that it intends to restart its previously disclosed $45 million rights offering. Great Elm Capital Group distributed non-transferable...
Nov 01, 2016 20:44 pm UTC| Business
VERNAL, Utah, Nov. 01, 2016 -- Superior Drilling Products, Inc. (NYSE MKT:SDPI) (“SDP” or the “Company”), a designer and manufacturer of drilling tool technologies, today announced that it will release its third quarter...
Nov 01, 2016 20:40 pm UTC| Business
TEL-AVIV, Israel, Nov. 01, 2016 -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (TASE:RDHL) (“RedHill” or the “Company”), a biopharmaceutical company primarily focused on the development and commercialization of late...